Scheller J - Search Results

1

The IL-6/sIL-6R complex as a novel target for therapeutic approaches.

Rose-John S, Waetzig GH, Scheller J, Grötzinger J, Seegert D. Rose-John S, et al. Among authors: scheller j. Expert Opin Ther Targets. 2007 May;11(5):613-24. doi: 10.1517/14728222.11.5.613. Expert Opin Ther Targets. 2007. PMID: 17465721 Review.

2

Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.

Scheller J, Kovaleva M, Rabe B, Eichler J, Kallen KJ, Rose-John S. Scheller J, et al. J Immunol Methods. 2004 Aug;291(1-2):93-100. doi: 10.1016/j.jim.2004.05.002. J Immunol Methods. 2004. PMID: 15345308

3

No inhibition of IL-27 signaling by soluble gp130.

Scheller J, Schuster B, Hölscher C, Yoshimoto T, Rose-John S. Scheller J, et al. Biochem Biophys Res Commun. 2005 Jan 28;326(4):724-8. doi: 10.1016/j.bbrc.2004.11.098. Biochem Biophys Res Commun. 2005. PMID: 15607729

4

IL-6 transsignaling: the in vivo consequences.

Jones SA, Richards PJ, Scheller J, Rose-John S. Jones SA, et al. Among authors: scheller j. J Interferon Cytokine Res. 2005 May;25(5):241-53. doi: 10.1089/jir.2005.25.241. J Interferon Cytokine Res. 2005. PMID: 15871661 Review.

5

Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Stuhlmann-Laeisz C, Lang S, Chalaris A, Krzysztof P, Enge S, Eichler J, Klingmüller U, Samuel M, Ernst M, Rose-John S, Scheller J. Stuhlmann-Laeisz C, et al. Among authors: scheller j. Mol Biol Cell. 2006 Jul;17(7):2986-95. doi: 10.1091/mbc.e05-12-1129. Epub 2006 Apr 19. Mol Biol Cell. 2006. PMID: 16624864 Free PMC article.

6

Interleukin-6 trans-signalling in chronic inflammation and cancer.

Scheller J, Ohnesorge N, Rose-John S. Scheller J, et al. Scand J Immunol. 2006 May;63(5):321-9. doi: 10.1111/j.1365-3083.2006.01750.x. Scand J Immunol. 2006. PMID: 16640655 Free article. Review.

7

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.

Rose-John S, Scheller J, Elson G, Jones SA. Rose-John S, et al. Among authors: scheller j. J Leukoc Biol. 2006 Aug;80(2):227-36. doi: 10.1189/jlb.1105674. Epub 2006 May 17. J Leukoc Biol. 2006. PMID: 16707558 Review.

8

Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling.

Lin M, Rose-John S, Grötzinger J, Conrad U, Scheller J. Lin M, et al. Among authors: scheller j. Biochem J. 2006 Sep 15;398(3):577-83. doi: 10.1042/BJ20060544. Biochem J. 2006. PMID: 16716147 Free PMC article.

9

Interleukin-6 and its receptor: from bench to bedside.

Scheller J, Rose-John S. Scheller J, et al. Med Microbiol Immunol. 2006 Dec;195(4):173-83. doi: 10.1007/s00430-006-0019-9. Epub 2006 May 31. Med Microbiol Immunol. 2006. PMID: 16741736 Review.

10

gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes.

Tenhumberg S, Schuster B, Zhu L, Kovaleva M, Scheller J, Kallen KJ, Rose-John S. Tenhumberg S, et al. Among authors: scheller j. Biochem Biophys Res Commun. 2006 Aug 4;346(3):649-57. doi: 10.1016/j.bbrc.2006.05.173. Epub 2006 Jun 6. Biochem Biophys Res Commun. 2006. PMID: 16774741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results